Summit Therapeutics Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 24, 2025 Deadline to file Lead Plaintiff Motion.

Core Viewpoint - Summit Therapeutics Inc. is facing a class action lawsuit due to allegations of making false and misleading statements regarding its Pinnacle Study of poziotinib, impacting investors who purchased securities during the specified Class Period [3]. Group 1: Class Action Details - The class action represents investors who bought securities between March 17, 2022, and September 22, 2022, with a deadline of September 24, 2025, to file a lead plaintiff motion [1]. - Investors are encouraged to contact the Portnoy Law Firm for a complimentary case evaluation and to discuss their legal rights [2]. Group 2: Allegations Against Summit - The complaint alleges that Summit's public statements regarding the results of its Pinnacle Study were materially false and misleading, leading to investor damages when the truth was revealed [3].